canakinumab

(Ilaris®)

Description:

DDD: 2.7 mg

Clinical Syndromes:

Morphological Classes:

References:

NOTE: the following reference list is generated automatically and has not yet been verified.
Automatic PUBMED search: ("Ilaris®/adverse effects"[Mesh] OR "Ilaris®/toxicity"[Mesh]) AND (nephrotoxicity OR "Kidney Diseases/chemically induced"[Mesh] OR "Kidney Diseases/pathology"[Mesh] OR "Kidney Diseases/physiopathology"[Mesh])

loading references for 'canakinumab' from pubmed ...

Case Reports: